PNC Financial Services Group’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
Other funds holding ELDN
PNC Financial Services Group's ELDN Position: Q3 2026 in Review
PNC Financial Services Group reduced its Eledon Pharmaceuticals (ELDN) stake by 68% in Q3 2026, selling an estimated $2.51K and leaving 354 shares worth $896. The position accounts for ﹤0.01% of the portfolio, ranked #5026.
PNC Financial Services Group first reported a position in ELDN in Q3 2025 and has held it in 5 quarters since. The position peaked at $4.34K in Q2 2026. 155 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.
- PNC Financial Services Group held 354 shares of Eledon Pharmaceuticals worth $896 as of Q3 2026.
- PNC Financial Services Group sold 748 Eledon Pharmaceuticals shares in Q3 2026, an estimated $2.51K.
- Eledon Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #5026 holding.
- PNC Financial Services Group first reported a position in Eledon Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- PNC Financial Services Group's Eledon Pharmaceuticals position peaked at $4.34K in Q2 2026.
- 155 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.